Ronald W. Barrett - 07 Sep 2021 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Maria Dobek, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
07 Sep 2021
Net transactions value
$0
Form type
3
Filing time
09 Sep 2021, 17:26:47 UTC
Previous filing
11 Jun 2021
Next filing
16 Jun 2022

No securities are beneficially owned.